Jinyu Bio-Technology Hits Day Low of CNY 13.14 Amid Price Pressure

Jinyu Bio-Technology Co., Ltd. experienced a significant decline today, with the stock dropping by 10.0% and reaching an intraday low of CNY 13.14. This performance stands in contrast to the broader market, as the China Shanghai Composite index fell by 3.63% on the same day. Over the past week, Jinyu's stock has decreased by 13.1%, and its monthly performance shows a decline of 15.28%. Despite these short-term setbacks, the company has demonstrated a notable annual performance, with a return of 73.58% over the last year, significantly outperforming the China Shanghai Composite's 13.33% gain. However, the company faces challenges in management efficiency, reflected in a low Return on Capital Employed (ROCE) of 6.64%. Additionally, Jinyu has reported negative results for the last four consecutive quarters, with operating cash flow at its lowest point of CNY 303.08 million. The stock's high P/E ratio of 283.00 and a Price to Book ratio of 3.18 indicate a potentially expensive valuation relative to its earnings. As Jinyu navigates these financial metrics, its market position remains a focal point for stakeholders.